Yvonne Mowery is an Oncology physician affiliated with University of Pittsburgh. OpenAlex indexes 290 publications with 2,878 citations (h-index 26); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5230 Centre Ave
Pittsburgh, PA 152321304
Telephone
412-623-6720Provider last certified this registry record 19 Jan 2024.
Clinical trials
- Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Sponsor: National Cancer Institute (NCI)
- Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech, Inc.Program year20232 payments$36,364openpaymentsdata.cms.gov ↗
- Genentech, Inc.Program year20221 payment$18,750openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2023–2025 per NIH RePORTER. The latest:
- Targeting TRPV1-containing nerves for radiation-induced pain and oral mucositis
University of Pittsburgh at Pittsburgh
FY2025$238,500R21DE034106 - Targeting TRPV1-containing nerves for radiation-induced pain and oral mucositis
University of Pittsburgh at Pittsburgh
FY2024$198,750R21DE034106 - Employing Novel Primary Mouse Models of Head and Neck Cancer to Overcome Chemoradiation Resistance
University of Pittsburgh at Pittsburgh
FY2024$160,812K08DE029887
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi Study
International Journal of Radiation Oncology*Biology*Physics
2025 - SU2C-SARC032: A randomized trial of neoadjuvant RT and surgery with or without pembrolizumab for soft tissue sarcoma.
Journal of Clinical Oncology
2024 - NETosis Impact on Tumor Biology, Radiation, and Systemic Therapy Resistance
Clinical Cancer Research
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Toren Finkel, MD/PHD
University of Pittsburgh
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Jared Magnani, MD, MSc
University of Pittsburgh
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”